•
Dec 31, 2015

EyePoint Pharmaceuticals Q2 2016 Earnings Report

Total Revenue
$526K
Previous year: $521K
+1.0%
EPS
-$1.8
Previous year: -$1.4
+28.6%
Gross Profit
-$3.2M
Previous year: -$2.25M
+42.3%
Cash and Equivalents
$11.2M
Previous year: $29.8M
-62.3%
Total Assets
$24M
Previous year: $40.2M
-40.4%

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals